PreveCeutical's collaboration with UniQuest and The University of Queensland, Australia has led...
Featured articles
In an industry that has grown-up rapidly in the past few years and established its credibility,...
Social first has allowed sites like UNILAD to amass a huge audience with very little capital...
The Parsortix system was used to capture and assess circulating tumour cells (CTCs) – the tiny...
ReNeuron Group PLC is at the forefront of stem cell science
Driving growth was Lojuxta, used to treat a rare and life-threatening disorder that causes...
Featured companies
ImmunoPrecise Antibodies Ltd. is a public company listed on the TSX Venture Exchange (TSXV: IP...
Avacta’s principal focus is on its proprietary Affimer® platform, a novel engineered alternati...
Arecor is a leader in developing superior biopharmaceuticals through the application of its in...
Q BioMed Inc. (OTCQB: QBIO) is a biomedical acceleration and development company. We are focus...
C4X Discovery aims to become the world's most productive drug discovery engine by exploiting c...
Synairgen is a drug discovery and development company founded by University of Southampton Pro...
Global biotech Newswire
PreveCeutical's collaboration with UniQuest and The University of Queensland, Australia has led...
In an industry that has grown-up rapidly in the past few years and established its credibility,...
Social first has allowed sites like UNILAD to amass a huge audience with very little capital...
The Parsortix system was used to capture and assess circulating tumour cells (CTCs) – the tiny...
SkinBio said Stuart John Ashman’s appointment would allow him to gain an understanding of the...
"I'm very pleased that Rob will serve as full-time chief financial officer and on behalf of the...
The company has a portfolio of medical products in market and final stages of testing.
ReNeuron Group PLC is at the forefront of stem cell science
Driving growth was Lojuxta, used to treat a rare and life-threatening disorder that causes...
Executive video interviews
PreveCeutical Medical Inc. (CNSX:PREV) Chairman and CEO Stephen Van Deventer joined...
Antibe Therapeutics (CVE:ATE, OTCQB:ATBPF) CEO Dan Legault joined Steve Darling from...
Khiron Life Sciences (CVE:KHRN) President Chris Naprawa joined Steve Darling from...
David Solomon, chief executive of Silence Therapeutics PLC (LON:SLN), updates Proactive...
Dyadic International Inc's (NASDAQ:DYAI) chief commercial officer Matthew Jones speaks...
BioCorRx Inc (OTCQB:BICX) CEO Brady Granier tells Proactive Investors the health care...
Hancock Jaffe Laboratories Inc (NASDAQ: HJLI) CEO Robert Berman tells Proactive...
Premier Health Care (CSE:PHGI-OTCQB:PHGRF) CEO Dr. Essam Hamza dropped in the Vancouver...
Ceapro Inc (CVE: CZO) CEO Gilles Gagnon tells Proactive Investors the company will soon...
CytoDyn Inc (OTCMKTS:CYDY) CEO Nader Pourhassan tells Proactive Investors the biotech is...
Trxade Group Inc (OTCQB: TRXD) CEO Suren Ajjarapu tells Proactive Investors the...
Life sciences group Integumen PLC (LON:SKIN) chief executive Gerry Brandon speaks to...
Big picture investment ideas in Biotech Capital
Social first has allowed sites like UNILAD to amass a huge audience with very little capital...
ReNeuron Group PLC is at the forefront of stem cell science
Summit Therapeutics' potential breakthrough targets C.difficile
The company’s cancer treatment is based on work undertaken by John Beard, a professor of...
The biotechnology company is developing a platform of unique drugs designed to prevent serious...
Danish giant Novo Nordisk recently signed up to use its NDD platform, and bosses expect more...
Chief executive Peter Butterfield said the company has started 2019 well-positioned for growth...
City broker Peel Hunt reckons the recent approvals “support the top-line forecasts in our model...
Geremy Thomas, founder and chief executive of Sativa, said the company has made significant...
Capital Network Research
Avacta - interim results confirm progress
April 09 2019
Avacta Group PLC (LON:AVCT) reported interim results to...
Judges Scientific's focus is paying dividends
April 04 2019
Judges Scientific PLC (LON:JDG) posted strong 2018 full year...
Shield Therapeutics PLC - Feraccru: a potential game changer in the...
January 18 2019
Feraccru is a unique, non-salt, formulation oral iron: strong...
Avacta Group - Maximising Affimer's potential across therapeutics and...
October 03 2018
Over the last year or so, management has delivered significant progress in bringing their...
Judges Scientific PLC - 2018 Interim Results
September 21 2018
Judges Scientific reported results for the first half of 2018. The period included a...
Legendary Investments - Hidden value potential
September 03 2018
Legendary Investments (LON:LEG) creates value through privately held and pre-market...
Partners:
